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The present review paper examines the use of diﬀerent types of polymeric matrix composites in hard tissue replacement applica-
tions. The review presents the actual state of the art in the ﬁelds of bioinert composites for permanent applications, biodegradable
matrix composites for temporary applications and the emerging area of injectable composites. In all cases some recent develop-
ments are also discussed. The paper starts with an introduction to locate the reader. Bone–analogue composites are then extensively
discussed. Several other systems based on an inert polymeric matrix are described, focusing on their proposed applications. A great
emphasis is afterwards given to biodegradable matrix systems. The most widely used synthetic bioresorbable systems are analysed
and compared with an example of natural origin degradable composites–starch based composites. Finally, composite systems that
are non-processable by melt based routes and in many cases injectable are discussed in detail, including several recent developments
on this emerging area of research.
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1. Introduction
The traditional deﬁnition of a composite material is a
material with at least two phases, a continuous phase
and a dispersed phase. The continuous phase is respon-
sible for ﬁlling the volume and transfer loads to the
dispersed phase. The dispersed phase is usually respon-
sible for enhancing one or more properties of the com-
posite. Most of the composites target an enhancement
of mechanical properties such as stiﬀness and strength,
but other properties may be of interest such as transport
properties (electrical or thermal) or density.
Matrix materials for composites can be metal, cera-
mic, polymeric or biologic. Fig. 1 shows the relation
between stiﬀness and strength for a number of materials
of interest for biomedical applications. It can be
observed that metals and ceramics are always stiﬀer and
can have larger strength than biologic hard tissue.
Polymers are mostly more compliant (lower modulus)
than hard tissue and can have strengths of the same
order of magnitude than hard tissue. Biological tissues
show larger spectra of mechanical properties than the
other materials. This picture clearly illustrates the great
interest of compounding polymers and other materials
to obtain composites that attain combinations of
mechanical and biological properties similar to those of
biological hard tissue.
As in other areas of biomedical research, nature is
seen in the area of biocomposites as a guide to design
new materials [1]. Mimicking the solutions found in
natural materials is one of the most promising ways to
reach the target set of properties needed in implant
materials.
The development of materials for any replacement
application should be based on the understanding of the
structure to be substituted. This is true in many ﬁelds,
but particularly exigent in substitution medicine. Thedemands upon the material properties largely depend on
the site of application and the function it has to restore.
Ideally, a replacement material should mimic the living
tissue from a mechanical, chemical, biological and
functional point of view.
Mineralised tissues such as bones, tooth and shells
have attracted considerable interest as natural aniso-
tropic composite structures with adequate mechanical
properties. In fact, nature is and will continue to be the
best materials scientist ever. Who better than nature can
design complex structures and control the intricate
phenomena (processing routes) that lead to the ﬁnal
shape and structure (from the macro to the ultra-
structural level) of living creatures? Who can combine
biological and physico-chemical mechanisms in such a
way that can arrive to ideal structure–properties rela-
tionships? Who, else than nature, can really design
smart structural components that respond, in-situ, to
exterior stimulus adapting the microstructure and cor-
respondent properties? In the described line of thinking,
mineralized tissues and biomineralization processes are
good examples to learn from for the materials scientist
of the future. This is especially true for engineers that
want to develop composites to replace mineralized
tissues.
The main characteristics of the route by which the
mineralised hard tissues are formed is that the organic
matrix is laid down ﬁrst and the inorganic reinforcing
phase grows within this organic matrix. Oyster shells,
coral, ivory, pearls, sea urchin spines, cuttleﬁsh bone,
are just a few of the vast variety of biomineralised
materials engineered by living creatures. Many of these
biological structural materials consist of inorganic
minerals combined with organic polymers. The study of
these structures has generated a growing awareness that
the adaptation of biological processes may lead to sig-
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smart-materials. To date, neither the elegance of the
biomineral assembly mechanisms nor the intricate com-
posite microarchitectures have been duplicated by non-
biological methods.
Bone, for instance, is a composite with variable den-
sity ranging from very dense and stiﬀ, the cortical bone,
to a soft and foamed structure, the trabecular bone.
Normally the outer part of long bones consists of cor-
tical bone, the density decreasing towards the core,
where the trabecular bone is found. The trabecular bone
is porous and the porosity is ﬁlled with osseous medula.
Structurally, the bone matrix consists of type I collagen
ﬁbres reinforced by hydroxyapatite nano-crystals pre-
cipitated along the collagen ﬁbres e.g. [2,3]. The mineral
part is responsible for the stiﬀness whereas the collagen
is responsible for its ﬂexibility. A demineralised bone
becomes very ﬂexible being easily twisted, whereas a
bone without collagen is very brittle [4].
The major component of compact bone is called the
osteon. Organised in concentric lamellar matrix, the
osteons create cylindrical conduits known as Haversian
canals, which provide access for the circulatory and
nervous systems. The capillaries within the Haversian
canals originate from arteries and veins within the mar-
row cavity. It is known that the structure of bones is
continuously adapted to the stresses applied to it [5].
Thus, any substitution implant material, should be
compatible and not disturb signiﬁcantly the stress
environment of the surrounding living tissue [6]. Fromall the above discussion it becomes evident how diﬃcult
it is to design and produce materials that can be used on
replacement and ﬁxation of bones or for ﬁlling bone
defects, especially those that must work under load-
bearing conditions. That explains why synthetic materi-
als are only about 10% of the bone grafting market,
where autografts and allografts still reign.
The following sections will describe the eﬀorts focused
on the development and processing of both bioinert and
biodegradable polymeric matrix composites for repla-
cement (long-term or temporary) of hard tissues. Special
attention will also be given to injectable systems and to
non-melt based processing techniques. The authors
believe that both biomimetics and tissue engineering will
play an increasing role on the development of novel
materials for replacing mineralised tissues, but those
topics fall beyond the scope of the present review.2. Bioinert composites for permanent applications
2.1. Polyethylene-based composites
High-density polyethylenes (HDPE) with very high
molecular weight fractions such as ultra high molecular
weight polyethylene (UHMWPE) have found applica-
tion as a load bearing material in joint endoprostheses
[8–12]. The advantages oﬀered by UHMWPE include
[11] very good sliding properties, good impact strength,Fig. 1. Tensile strength vs. modulus of materials with relevance for composite design when considering biomedical applications (adapted from
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good fatigue resistance and good biocompatibility. In
the long term implantation, the behaviour of
UHMWPE is compromised by its insuﬃcient wear per-
formance, low stiﬀness and high creep compliance. The
attempts to enhance UHMWPE performance included
crosslinking [13–17] and carbon ﬁbre (CF) reinforce-
ment [18,19]. For the latter case, improvements in
strength, stiﬀness, as well as in creep resistance and
fatigue strength have been claimed [18,19]. In spite of
these results, another study [20] attributed a lower fati-
gue crack growth resistance and poor wear performance
to CF reinforced composites as result of mechanical
properties mismatch and lack of adhesion between the
two phases. Another approach, based on the self-rein-
forcement of UHMWPE [21], showed superior tensile
properties, creep resistance and impact strength with
maintenance of wear properties for the self-reinforced
UHMWPE composite material.
2.1.1. The bone analogue concept
Bonﬁeld et al. [22–48] proposed the use of composites
of HDPE with hydroxyapatite (HA), introducing the
so-called bone-analogue concept. The research motiva-
tion was the development of new biomaterials having
adequate biocompatibility and mechanical behaviour
that allow for their use on load bearing applications.
Historically, bone ﬁxation and total joint replacement
have been accomplished with the use of metals that
exhibit a much higher stiﬀness as compared with the
typical modulus of bone (between 7 and 25 GPa) [47–
49]. Under loading conditions, the diﬀerences in stiﬀ-
ness between the bone and the metal originate a stress-
shielding eﬀect, making most of the load to be carried
by the ﬁxation device. This tends to promote the osteo-
porosis phenomena [50], compromising tissue healing.
The starting point for the development of this bone
analogue composite system was the deﬁnition of the
respective mechanical performance requirements by
assessment of the typical bone mechanical behaviour in
the light of its intrinsic structure [24]. The attempts to
replicate bone mechanical behaviour was based on the
reinforcement of a ductile polymeric matrix (PE) with a
bone-like ceramic (HA), in which the ceramic assures
the mechanical reinforcement of the polymer and both
the bioactive character and the biocompatibility of the
composite [25–28]. Although not yet used in high load
bearing applications, the composites of HDPE/HA are
already used to produce middle ear implants, under the
trade-name HAPEX1 [46]. Alternative bioactive rein-
forcements have been also investigated for HDPE,
namely bioactive glasses [51–53] and glass-ceramic [53–
55]. Bioactive glass based composites exhibit lower
stiﬀness as compared to HDPE/HA composites with
similar HA content, but elicit a strong bioactive beha-
viour [51–55], making them specially suitable for soft
tissue applications.2.1.2. Mechanical behaviour dependence on interfacial
interaction and HA particle characteristics
The HA particle size and the respective distribution
have been recognized [29] as important parameters
aﬀecting the mechanical behaviour of HDPE/HA sys-
tem. Apparently, smaller particle size leads to stiﬀer
composites. Furthermore, the stiﬀness of HDPE/HA
composites is proportional to the HA volume fraction
[32]. Nevertheless, although the HA particles increase
the material stiﬀness and enhance the creep behaviour,
the higher the HA content, the higher the number of
interfaces between the polymer and the ceramic, which
has to be taken into account since failure can pre-
ferentially occur at the interface when the implant is
under mechanical loading [30,31]. Several studies by
Bonﬁeld and co-workers [39–43] pointed out the low
eﬃciency of the HA particles as reinforcement agents
for HDPE, due to its inherent low aspect ratio and low
degree of chemical interaction with the HDPE phase.
Attempts [39–43] to enhance the mechanical perfor-
mance investigated the chemical coupling of HDPE/HA
composites by means of silane agents and acrylic acid
grafting, allowed for the enhancement of strength and
ductility, but did not improve consistently the stiﬀness
[39]. The development of coupling methodologies that
increase the adhesion of the HA particles towards the
polymeric matrix is believed to be a possible route for
the improvement of mechanical performance of these
composites [45]. A parallel investigation [56] showed the
eﬀectiveness of silane coupling treatments to be depen-
dent on factors such as the particle surface area, the
particle size distribution and the chemical reactivity of
the HA particles. Another study [57], also conducted by
our research group, investigated the use of alternative
titanate and zirconate coupling agents and concluded
that the positive eﬀect of these agents on stiﬀness and
strength result from their dominant eﬀect as HA dis-
persion promoters [57]. These coupling agents proved to
be [58] clearly non-cytotoxic, which is a great advantage
when compared to standard silane coupling agents.
2.1.3. Processing routes for the inducement of
anisotropy: Hydrostatic Extrusion vs. Shear Controlled
Orientation in Injection Moulding (SCORIM)
Attempts by Bonﬁeld et al. [35–37] to develop bone-
matching mechanical performance have relied on the
inducement of a strong anisotropic character by means
of hydrostatic extrusion. The application of this solid-
state processing technique has enabled for the attain-
ment of signiﬁcant improvements in the composite stiﬀ-
ness. Values of modulus up to 13 GPa could be reported
[37]. A complementary approach has relied on the rein-
forcement of the HDPE/HA composites with high
modulus HDPE ﬁbres (HMPE) [31,38]. In this case, the
use of very stiﬀ and chemically compatible ﬁbres
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performance. Values of stiﬀness and strength within the
typical range of mechanical performance of human
bone have been reported with values of 17 GPa and 113
Mpa respectively [38]. An alternative approach to the
mechanical performance enhancement of HDPE/HA
composites was followed by Reis and co-workers [57,59]
with the use of shear controlled orientation injection
moulding (SCORIM). SCORIM operation is based on
the application of a macroscopic shear stress ﬁeld at the
melt/solid interface of the polymer during the mouldingcycle. This moulding technique proved to be a successful
approach for the inducement of an anisotropic char-
acter to high density polyethylene [60] and in the
respective composites reinforced with HA [57,59].
Values of stiﬀness between 5 and 7 GPa have been
reported [57,59] for HDPE/HA composites. X-ray dif-
fraction patterns and calorimetric studies on SCORIM
processed HDPE have revealed respectively signs of C-
axis orientation parallel to ﬂow direction and high levels
of crystallinity [60]. Several studies [57–59] revealed the
existence in SCORIM mouldings of a typical laminated
morphology indicating a high level of anisotropy, which
was found to be more evident for higher molecular
weight PE grades [59]. The higher anisotropy of higher
molecular weight materials is conﬁrmed by X-ray dif-
fraction and results from the extensive shish-kebab for-
mation during shear application [60,61]. These studies
show the relative importance of the molecular weight
characteristics of the HDPE on the attainment of high
anisotropic bone-analogue composites. Fig. 2 presents a
scanning electron microscopy photograph of a tensile
failure surface of a SCORIM processed HDPE, where a
concentric laminated morphology is evident. Table 1
summarises the mechanical properties of HDPE/HA
composites in terms of their stiﬀness and strength for
conventional injection moulding, SCORIM and also
hydrostatic extrusion.
2.1.4. Hybrid composites based on HDPE/HA
composites
In order to overcome the limitations of HA reinfor-
cement of HDPE, Sousa et al. [62,63] investigated the
selective replacement of the HA particles in the bulk of
moulded parts, where its use is not needed or advanta-
geous, by a very stiﬀ ﬁller, such as short CFs. This
would be a possible approach for the development of
mechanically strong biocompatible composites. Eﬀorts
have been made in order to develop sandwich mould-
ings comprising a HDPE/HA composite outer layer and
a HDPE/C ﬁbres composite core [63]. Upon mechanical
testing, the bi-composite sandwich mouldings exhibit
two distinct modes of fracture: a relatively brittle frac-
ture associated to the HA ﬁlled surface layer and more
ductile fracture mode related to CF reinforced moulding
core [63]. As a result of the HA loading, these sandwichFig. 2. Scanning electron micrographs of the tensile failure surface of
a SCORIM processed HDPE: (a) great view and (b) detail. The con-
centric laminated morphology exhibits signiﬁcant anisotropy and
develops during the application of a shear stress ﬁeld to the moving
melt-solid interface during cooling.Table 1
Reference mechanical properties in terms of the modulus (E), and tensile strength (TS) for HDPE/HA compositesaConventional injection
mouldingSCORIM Hydrostatic extrusionE (GPa) TS (MPa) E (GPa) TS (MPa) E (GPa) TS (MPa)HDPE 1.2–1.5 25–100 3.0–7.1 Up to 155 – –HDPE/HA 1.6–4.0 35–39 5.9–7.5 Up to 91 13–17 Up to 113a Adapted from References [37,38,57,59,61,64].J.F. Mano et al. / Composites Science and Technology 64 (2004) 789–817 793
bi-composite mouldings exhibit a clear in-vitro bioactive
behaviour, which indicates that an in-vivo bone-bonding
behaviour can be eventually expected for these materials.
As in typical injection mouldings, the properties of
such bi-composite parts vary along the moulding. As an
example, rectangular cross-section impact test bars were
injection moulded. Ten sample layers, with thickness of
0.9 mm were obtained by cutting a bar along its
length. Each sample was analysed by dynamic mechan-
ical analysis. The storage modulus, E0, at 23 and 37 C
(for a frequency of 1 Hz) is plotted in Fig. 3, as a func-
tion of the distance of the centre of the sample relatively
to the centre of the original sample bar. The storage
modulus corresponds to the real component of the
complex modulus, being a measurement of the stiﬀness
of the material. As expected, the stiﬀness is minimum at
the edges of the sample, because one is essentially mea-
suring the HDPE/HA layer. E0 increases as one goes
though the centre due to the stiﬀer HDPE/C material.
However, at the mould centre, the corresponding layer
exhibit a lower E0, being assigned to the less ﬁbre orien-
tation as compared to the region next to the HDPE/C
phase. In fact, the inner HDPE/C phase, possess a skin-
core morphology, where higher ﬁbre orientations are
achieved at the skin regions.
2.2. Other inert polymer composite systems in hard
tissue substitution
2.2.1. Polymer composite systems
Generally, tissues are grouped into soft and hard tis-
sues. Bone and tooth are examples of hard tissue
whereas skin, blood vessels and cartilage are examples
of soft tissue. Accordingly, hard tissues are intended to
support loads, being stiﬀer (higher elastic modulus) andstronger (higher tensile strength) than soft tissues. The
need for mechanical compatibility with hard tissue
makes metals and ceramics to be many times considered
more suitable than polymers for those type of applica-
tions. However, this is not true in many cases, basically
because metals are much stiﬀer than human hard tissues
and ceramics are not only more brittle but also stiﬀer
than natural mineralised tissues. On the other hand
unreinforced polymers are typically more ductile but
not stiﬀ enough to be used to replace hard tissues in
load-bearing applications. Nevertheless, polymer based
composites can be designed to meet stiﬀness and
strength requirements for hard tissue substitution. Sev-
eral examples of diﬀerent systems will be discussed in
this review.
The discontinuous phase of polymer composites can
be of the same nature or, more commonly, of a diﬀerent
type of material. Polymer matrix composites are being
increasingly studied for diﬀerent applications ranging
from coatings, load-bearing implants or biosensors [65].
Examples of polymers proposed as matrices in bio-
medical composites include poly(methylmethacrylate)
(PMMA), polysulfone (PSU), poly(etheretherketone)
PEEK or Epoxy resins. The requirements for a polymer
material to be used in those applications include fatigue
resistance, resistance to ageing in saline aqueous media,
biocompatibility, dimensional stability, absence of
migrating harmful additives and being sterilisable by
standard methods without loss of properties. The bio-
compatibility requirement includes that the material and
its additives are accepted by the surrounding tissue with-
out toxic, inﬂammatory or allergic reaction [66].
The most common reinforcements for polymer matrix
composites are glass and CFs. Other synthetic reinfor-
cements are also available such as aramid ﬁbres (Kevlar)
as well as natural ﬁbres such as bamboo [67]. The most
interesting reinforcement materials for bone related
implants or tissue substitutes are bioactive ﬁllers. Exam-
ples of those bioactive ﬁllers are HA and bioactive glasses.
Bioactive glass is a special type of glass which has aﬃnity
with mineral bone, enabling to obtain both mechanical
reinforcement and bioactivity in polymer matrix compo-
sites (e.g. [68,69]). Those reinforcements have been sub-
jected to extensive research eﬀort in recent years.
The greatest advantage of composite materials is that
they oﬀer the possibility of tailoring its properties by
playing with the volume fraction of the discontinuous
phase, dimension of the particles (particularly when in
ﬁbre form), and its orientation [70]. This way it would
be possible to avoid the mismatch stiﬀness between the
properties of metal implants and bone, leading to the
stress shielding eﬀect [71,72]. One of the key parameters
in controlling the successful design of polymer matrix
composites is the eﬃcient control of the interface
between the continuous phase (polymer) and the
discontinuous phase (reinforcement).Fig. 3. Micrograph showing the cross-section of a bi-composite bar
(cross-section dimensions: 612.7 mm2). The dark region correspond
to the CF reinforced moulding core whereas the HA ﬁlled surface
layer appear as the clear region. Graphics–Storage modulus of samples
obtained from cutting an original bi-composite bar though vertical
lines over the cross-section, as a function of the distance to the mould
centre of the initial bar. The tests were performed using a DMA7e
Perkin-Elmer equipment, in a three point bending mode.794 J.F. Mano et al. / Composites Science and Technology 64 (2004) 789–817
The most promising polymer composites as alter-
natives to metal based implants such as plates, pins or
nails are carbon or glass ﬁbre reinforced PEEK, PSU or
Epoxy. Other systems with potential for those applica-
tions include the same polymer matrix materials but
reinforced with HA and bioactive glasses. Those sys-
tems and its properties will be discussed in the following
sections of this review.
2.2.1.1. Polysulfone (PSU) composite systems. Medical
grades of polysulfone are commercially presenting as
combining high strength, being biologically inert, dis-
playing unique long-life under sterilization procedures
and being resistant to most common hospital chemicals
[73].
Latour and Black [74] studied the eﬀect of simulated
in vivo environments such as saline and exudates on the
ﬁbre/matrix interfacial bond for PSU composites rein-
forced with carbon and polyaramid (Kevlar 49) ﬁbres.
They observed signiﬁcant degradation of the interface
properties under fatigue stresses and attributed the
degradation to the eﬀect of water and salt ions. The CF/
PSF interface experienced fatigue failure at approxi-
mately 105 load cycles at a maximum applied load level
of only 15% of its ultimate dry bond strength without
indication of an endurance limit being reached. Those
results raise some important questions regarding the
durability of CF/PSU composite in load bearing
orthopaedic applications.
In a study aiming at using polysulfone for the culti-
vation of osteogenic cells (preosteoblast-like MN7 cells
and primary bone marrow fragments) it was observed
that the material did not interfere with the proliferation
in early stages of bone-forming cells [75]. However the
polymer prevented the ﬁnal steps of matrix formation as
measured by collagen synthesis and matrix mineraliza-
tion. The data reported argues against polysulphone as
a material for orthopedic implants.
Marcolongo et al. [76] examined the bone tissue
response to a bioactive glass ﬁbre/PSU composite
implant. Bone tissue exhibited direct contact with the
glass ﬁbres and adjacent polymer matrix and displayed
a mechanical bond between the composite and bone
tissue after 6 weeks. The ﬁbres resorbed to diﬀerent
degrees and were replaced by calciﬁed tissue resulting in
interfacial bond strengths which were signiﬁcantly
higher than all polymer controls after the 6 weeks
implantation.
2.2.1.2. Carbon fibre reinforced polyetheretherketone
(CF/PEEK) systems. PEEK compounds are high per-
formance engineering polymers and oﬀer good bio-
compatibility and tolerance by in vivo tissue [77–81].
Zhang et al. [82] studied the long-term compressive prop-
erties under physiologic saline conditions of AS4/APC-2
PEEK-61% in volume continuous CF unidirectionalcomposites. It was shown that the material has high
stability and applicability for structural permanent
orthopaedic implants. Brown et al. [83] reported similar
behaviour in the case of short CF reinforced PEEK
showing that it does not undergoes degradation of the
interface and mechanical property loss under saline
environments. However it should be noted that short
CFs do not allow to obtain so high stiﬀness and
strength as with continuous ﬁbre composites.
Recently, Abu Bakar et al. [84] proposed the use of
HA/PEEK composites for orthopaedic implants for
bone substitution. This work highlighted the mechanical
properties achieved by reinforcing PEEK with thermal
sprayed HA particles. The materials were ﬁrstly com-
pounded and then injection moulded. The mechanical
properties were shown to increase monotonically with
the reinforcement concentration, with a maximum value
in the study of 40% volume fraction of HA particles.
The range of stiﬀness reported of 2.8–16.0 GPa and of
strength 45.5–69 MPa crossing the lower bound of the
properties of human bone (7–30 GPa, 50–150 MPa,
respectively).
Wear between bone and CF/PEEK composites is an
active area of research (e.g. [85,86]). Fretting and sliding
abrasive wear tests resulted in the composite material
exhibiting a lower wear rate than titanium-alloys. Cur-
rently, studies are underway to develop PEEK
reinforced with braided CF structures [87].
2.2.1.3. Carbon fibre reinforced epoxy systems. CF rein-
forced epoxy is radiolucent, heat-resistant, extremely
strong and light (its density is 20% that of steel), has a
modulus of elasticity close to that of bone, and an
established biocompatibility [88]. The biocompatibility
of CF reinforced epoxy composites has also been
reported in a number of works [89–91]. Fujihara [92]
has reported that composites made of braided carbon
ﬁbres and epoxy resins have better mechanical proper-
ties than composites made of short or laminated uni-
directional ﬁbres. He has also demonstrated that
braided fabric reinforced composites made of carbon
ﬁbre and epoxy resin could be used to produce bone
plates.
The use of a semi-rigid carbon ﬁbre reinforced epoxy
plate was tested over a mean follow-up period of 3.3
years for cranioplasty. Five patients, all of whom were
elderly women with severe osteoporosis and highly
restricted mobility showed no adverse reactions to the
plate. It was concluded that prefabricated CF/Epoxy
medical grade implants can be considered as an alter-
native to conventionally clinically utilised materials [93].
2.2.2. Internal ﬁxation of bone fractures
The study of polymer composites for hard tissue
applications has been mostly directed to joint prosthe-
sis, bone plates and nails. Of those, the most importantJ.F. Mano et al. / Composites Science and Technology 64 (2004) 789–817 795
and demanding applications are the hip and knee pros-
thesis. Key requirements for the materials in those
applications besides the biocompatibility and stress
protection during healing include the fatigue fracture
resistance and wear resistance. We will review some of
the implants in use and the attempts to use ﬁbre rein-
forced polymer composites in those highly demanding
applications.
Internal ﬁxation requires the use of implants to keep
bone fragments together and include the use of pins,
nails, screws or plates. Non-resorbable materials are
temporary implants that may be removed after success-
ful healing of the bone fracture. Plate and screw ﬁxation
is the most popular method of rigid internal ﬁxation of
bone fracture. They are mostly made of stainless steel,
Cr–Co or Ti alloys [94,95]. This ﬁxation is intended to
provide resistance to dynamic stresses allowing the bone
to heal and avoiding the formation of callus at the
fracture site. The rigid ﬁxation however, may be
responsible for bone atrophy caused by the stress
shielding eﬀect previously mentioned [69]. In fact, stud-
ies have shown that the magnitude of bone atrophy in
Ti alloy (110 GPa) plates is smaller than the one
observed in stainless steel plates (210 GPa) [69,96]. This
observation suggests that plates with closer stiﬀness to
the one of bone would minimise the stress-shielding
eﬀect. Furthermore some concerns subsist about the
immuno-inﬂammatory response of soft tissue around
stainless steel and Ti implants [97–99].
2.2.2.1. Total hip replacement. Modern total hip
arthroplasty has been performed using femoral stems
manufactured from stainless steel, cobalt–chrome
molybdenum alloy (CoCrMb), titanium aluminium
vanadium alloy (TiAlV), and, on a limited basis, poly-
mer matrix composites. Today, only CoCrMb and
TiAlV are used in signiﬁcant numbers [100]. There is
ample theoretical, experimental, and clinical evidence to
support TiAlV as the material of choice for cementless
femoral stems, based on superior mechanical compat-
ibility and biocompatibility. The primary advantage of
TiAlV over CoCrMb is a lower modulus of elasticity
when compared with stainless steel. This results in
decreased stress shielding and subsequent favourable
femoral remodelling around the implant. This eﬀect is
more signiﬁcant with the smaller stem sizes used in pri-
mary surgery but persists even with larger stem sizes
used in revision surgery. The second advantage of
TiAlV is its biocompatibility. Titanium–aluminium
vanadium alloy is of relatively low–toxicity in con-
centrations found clinically, and TiAlV is inert in the
physiologic environment. With regard to ﬁxation in
cementless total hip arthroplasty, TiAlV has been
shown to achieve excellent bone ingrowth into porous
surfaces. In addition, there is evidence of superior bony
ingrowth into TiAlV as compared with CoCrMb. Tita-nium–aluminium–vanadium alloy is presently the mate-
rial of choice to be used in conjunction with
hydroxyapatite coating. Prosthetic design, stem dia-
meter, and porous-coating applications play signiﬁcant
roles in bony response regardless of metal composition.
Hedia et al. [101] performed a material optimisation
study of the femoral component of a hip prosthesis
based on the fatigue notch approach. The overall
objective of the optimisation was to maximise the stres-
ses supported by the proximal bone whilst at the same
time constraining the stress ﬁeld at all cement interfaces
to be no greater than its initial value. The results of the
ﬁrst study suggest that Young’s moduli of about 145
and 210 GPa are optimal for the monolithic metal and
optimised stems, respectively. A composite prosthesis
with a layer of modulus 31 GPa added to the optimised
stainless steel stem in the proximal region only, was
found to signiﬁcantly increase the stresses in the prox-
imal bone and reduce the stresses in the cement whilst
retaining the advantages of an outer stem proﬁle very
similar to that of the original metal prosthesis.
A comparative stress analysis of a polymeric compo-
site hip joint replacement was performed by Akay and
Aslan [102]. A prototype short carbon-ﬁbre reinforced
PEEK prosthesis was manufactured by injection mold-
ing. Finite element analysis was conducted on intact
femurs and femurs ﬁtted with the CF/PEEK and the
titanium prostheses under various loading conditions.
Finite element models were validated by experimental
strain gauge measurements by using synthetic femurs.
Agreement between the two methods was obtained
except in the hoop strain of the femur in the calcar
region because of the assumption of the isotropic mate-
rial properties. The stem stresses were lower for the CF/
PEEK prosthesis than for the titanium prosthesis. The
maximum stress was in the spigot of the CF/PEEK
prosthesis, but in the middle third of the stem of the
titanium prosthesis. Stress generated in the cement was
almost equal for both prostheses although more load
was transferred, via cement, to the femur with the CF/
PEEK prosthesis because the load transfer took place
over a larger area.
Jacobsson et al. [103] compared two cementless
femoral components, a composite stem and the more
rigid metal design, in a randomised, prospective study
of 56 patients with a mean follow-up of 4 years. Patients
were matched in 28 pairs, and one of each pair was
treated with each femoral component. The composite
stem gave fewer signs of stress shielding radiologically,
but showed signiﬁcantly inferior results at the 2-year
and 3-year follow-up in terms of patient pain. The
overall failure rates for the femoral components were
43% for the composite and 11% for the metal. These
results contrast with those of earlier experimental and
clinical studies, in which isoelastic composite/bone
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2.2.2.2. Unicompartmental and total knee replacement.
There is some evidence for a large unmet need for these
surgeries [104], and with the ageing of the population it
is likely that demand will increase [105]. There are
unsolved problems with these procedures. The knee
replacement is not totally safe, having a signiﬁcant inci-
dence of peri- and post-operative mortality and mor-
bidity. Those operations are expensive, and the relative
cost-eﬀectiveness of surgery when compared with more
conservative interventions, still needs to be shown.
There are a proportion of patients who do not obtain
the great beneﬁts in pain and function or in whom the
prosthesis fails after a relatively short time [106]. Thus,
there is a need to learn how to improve the value of
knee replacement surgery, aiming at improving materi-
als, design and surgical methods to maximise patient
beneﬁt.
Knee replacement surgery is indicated on the treat-
ment of severe knee arthritis [107]. A variety of recent
reviews have been published concerning both uni-
compartmental and total knee replacements [108–110].
A trial was made to use polyethylene and CF/poly-
ethylene composite materials for knee replacement [111]
the result not being promising. Those results hindered
further research on the application of composites for
total knee replacement.
2.2.2.3. Screws, plates, nails. A composite material of
PEEK and short, chopped E-glass ﬁbres was used to
produce a segmental bone replacement implant [112].
Composite materials were chosen because their proper-
ties can be tailored to match the requirements. Material
selection was accomplished with the aid of modeling
software, which predicted the composite properties
based on its composition and ﬁbre directional para-
meters. The moulded parts were characterized both
destructively and non-destructively. The results of ten-
sile tests performed on moulded parts were comparable
to those using commercially supplied samples.
A method of securing CF-reinforced epoxy bone
plates with CF polysulfone expanding rivets was inves-
tigated [113]. Six CF-reinforced epoxy bone plates were
secured to rods with CF polysulphone rivets and six
were secured with standard cortical stainless steel
screws. These constructions were then subjected to pure
torsional load to failure. The CF expandable rivets
failed at a greater torsional moment making them
attractive for this application.
The suitability of a braided CF-epoxy composite for
bone plate application was studied by Veerabagu et al.
[93]. They have shown, based in ﬁnite element calcula-
tions, that the strain and stress supported by those plates
is able to overcome the stress shielding problem without
leading to ﬁbre/matrix debonding on the composite.
Schandelmaier et al. [114] studied the biomechanics of
femoral interlocking nails. They concluded that it is theproﬁle which is decisive for the torsional stiﬀness of
femoral locking nails in the bone implant complex. The
presence of a slot in the proﬁle is of special importance.
Unslotted nails have a signiﬁcantly higher torsional
stiﬀness than slotted nails.
Al-Shawi et al. [93] reported the use of carbon ﬁbre
reinforced epoxy plates for periprosthetic supracondylar
femoral fractures. The plates were made by pressurized
heat lamination of carbon ﬁbre sheets preimpregnated
with epoxy resin and placed in a mould in a pre-
determined order and orientation. The advantages are
highlighted in fractures involving poor-quality bone and
particularly in the treatment of distal femoral fractures
in the elderly. In their study the patients were elderly
with marked osteoporosis and with poor mobility.
2.2.2.4. Spinal implants. Rivard et al. [115] proposed a
new spinal implant system (SIS) without fusion (bone
graft). In an FDA recommended in vivo testing (animal
model), it was assessed whether the PEEK polymer
could be used in a SIS without any harm of wear debris
to the nervous tissue (spinal cord and nerve roots).
Evaluation took place at 1, 4, and 12 weeks’ post-
surgery. The macroscopic and semiquantitative histolo-
gic analyses of the spinal cords (dura mater) showed
normal vascularization and particle adherence to the
connective tissue especially at the injection sites. Neither
necrosis nor swelling of the dura mater and nerve roots
was observed. Those results give good indications about
PEEK polymer eﬀect on the spinal cord and thus it seems
usable as component in the spinal implant system.3. Biodegradable composites
3.1. Synthetic bioabsorbable polymers
Much research work has been devoted to the produc-
tion of bioabsorbable surgical devices that could avoid a
surgical operation for their removal, thereby reducing
the pain of the patients and the total cost of the treat-
ment when compared, for example, to the use of metal-
lic devices. In this case, the stress-shielding phenomena
associated with the use of rigid metallic implants could
also be minimised. The continuous degradation of the
implant causes a gradual load transfer to the healing
tissue, preventing stress-shielding atrophy and stimu-
lates the healing and remodelling of the bone. Some
requirements must be fulﬁlled by ideal prosthetic bio-
degradable materials, such as biocompatibility, ade-
quate initial strength and stiﬀness, retention of
mechanical properties throughout suﬃcient time to
assure its biofunctionality and non-toxicity of degradation
by-products [116,117].
Poly(a-hydroxy esters), such as poly(l-lactic acid)
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poly(dl-lactic-co-glycolic acid) (PLGA) are among the
few synthetic polymers approved for human clinical
uses, including those for small load-bearing applications
[118,119]. As seen further in the text, they exhibit bio-
compatibility, biodegradability and are easily processed
by conventional melt based routes. A review of the
general properties of lactic acid based polymers can be
found elsewhere [120,121]. The diﬀerent ways of produ-
cing such materials, such as polycondensation, ring-
opening polymerisation, chain extension and grafting,
are also presented in that work. The main features of
PGA, and especially its application for devices in trauma
and bone surgery, were reviewed by Ashammakhi and
Rokkanen [122].
Other materials of relevance includes poly(ortho
esters), poly(glycolide-co-trimethylene carbonate),
poly(p-dioxanone), poly(anhydrides), poly(e-capro-
lactone) (PCL), poly(b-hydroxybutyrate) (PHB) and
poly(PHB-hydroxyvaleric acid). A list of references on
those materials can be found in ref. [117]. A review of
the synthesis of diﬀerent biodegradable polymers can
also be found elsewhere [123].
3.1.1. Degradation of Poly(-hydroxy esters)
l-Lactic acid occurs in the metabolism of all animals
and microorganisms, and thus, it is in theory an abso-
lutely non-toxic degradation product of (co)polylac-
tides. Glycine is ultimately formed during degradation
of PGA which can also enter the tricarboxylic acid cycle
and be metabolised into water and carbon dioxide.
There is a general consensus that degradation of
poly(a-hydroxy esters) in the aqueous media proceeds
via a random, bulk hydrolysis of the ester bonds in the
polymer chain. This process is catalysed by the ends of
the carboxylic chains that are produced during the ester
hydrolysis [124]. During degradation, the soluble oligo-
mers which are close to the surface of the piece leach out
towards the aqueous medium faster than the chains
located inside the matrix. This gradient of concentration
in acidic groups leads to the formation of a skin com-
posed of less degraded polymer [125–127]. The existence
of diﬀusion of the degraded products explains the delay
between the decrease of mechanical properties and
decrease of molecular weight. PLA is much more
hydrophobic than PGA due to the additional methyl
group in the structure of PLA. Therefore PGA degrades
much more quickly (a few weeks [128,129]) than PLA,
which can remain stable for over 1 year [130], or more
depending on its degree of crystallinity. Copolymers of
PLA and PGA do not have interpolated properties of
the pure components: for example, copolymers con-
taining equal ratios of PGA and PLA degrade faster
than pure PGA.
The degradation in semi-crystalline polyesters under-
goes preferentially within the amorphous regions because
of a higher rate of water uptake than the crystallineregions. The degraded segments could then diﬀuse and
give rise to recrystallization; this increase of crystallinity
during hydrolytic degradation can be detected from the
whitening of the specimens [131].
3.1.2. SR-composites from Poly(-hydroxy esters)
PLLA have intrinsically interesting mechanical prop-
erties with an approximate tensile modulus of 3–4 GPa,
tensile strength of 50–70 MPa, ﬂexural modulus of 4–5
GPa, ﬂexural strength of 100 MPa and a strain break of
about 4% [120,132,133]. The mechanical properties of
PLLA may however vary with molecular weight and
crystallinity [134]. For PGA, the tensile modulus and
strength can reach 6–7 Gpa and 60–100 MPa, respec-
tively, and a strain at break between 1.5 and 20%
[132,133,135]. Again, such values are highly dependent
on the molecular weight and crystallinity. The mechan-
ical behaviour of such materials is not enough to be
used is many orthopaedic applications, such as for the
ﬁxation of fractures and osteotomies and as interference
screws for ligament repairs.
Alternative processing routes of poly(a-hydroxy
esters) have been proposed in order to produce speci-
mens with enhanced mechanical properties. It was
shown that PLLA and PGA ﬁbres exhibiting an high
orientation structure can be produced by mechanical
deformation, using well-known processing methods
from the polymer technology, such as oven drawing,
zone drawing, zone annealing, die drawing, hydrostatic
extrusion or rolling. For example, by melt-spinning,
ﬁbres of PLLA can present 390–1800 MPa of tensile
strength and 6.5–9.3 GPa of tensile modulus [136–140].
By solution-spinning, PLLA ﬁbres can reach 560–2300
MPa of tensile strength and 9.6–16 GPa of tensile mod-
ulus [136,141]. PGA can also be spun into the ﬁbre form,
when the molecular weight is 20 000 to 145 000 [142].
The sintering of such ﬁbres at high temperature and
pressures allows to produce composite devices (that can
be, for example, rods, screws, tacks, plugs, arrows and
wires) in which the polymer matrix is reinforced with
the same material [143–145]. Such self-reinforced (SR)
materials exhibit a signiﬁcant mechanical improvement
over all mechanical properties, relatively to the corre-
sponding isotropic materials. For example, Manninen
[146] reported a study from Pohjonen et al. [147], where
injection moulding PGA, sintered SR-PGA and hot-
drawn PGA rods with 2 mm diameter presented bend-
ing modulus of 7, 10 and 13 GPa; bending strengths of
218, 260 and 330 MPa and shear strengths of 95, 192
and 260 MPa, respectively. For SR-PLLA screws, very
good initial properties could also be observed, with
bending moduli of 7 GPa; bending strength of 200 MPa
and shear strength of 110 Mpa [145]. The shear strength
decreased to 65 MPa (76 MPa in vitro) and 35 MPa (80
MPa in vitro) after 12 and 24 weeks of degradation in
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aggressive eﬀect felt by implants on in vivo conditions.
Another study of in vivo and in vitro (static and
dynamic) degradation in polylactides were reported by
Mainil-Varlet et al. [148], where parameters such as
crystallinity, molecular weight, mechanical properties
and morphology are followed against degradation time.
Data on degradation of PLA, PGA and other polymers
where also collected by An et al. [117], being possible to
observe that the degradation time of biodegradable
pieces in vivo could depend strongly on their geometry
and test conditions. Another study by To¨rma¨la¨ et al
[149] on SR-PGA rods demonstrated that the strength
of some specimens could be retained over 8 weeks.
The degradation time of implants may have implica-
tions in the tissue reactions on the degradation pro-
ducts. If the degradation is fast, the degradation
products may not have time enough to be absorbed, due
to poor vascularization or low metabolic activity. For
example, PGA implants have been found to produce
ﬂuid-ﬁlled sterile sinuses with subsequent drainage, due
to increase of osmotic pressure or pH [150,151]. This
could happen 8–16 weeks after the operation [152]. As
PLLA implants degrade much more slowly (SR-PLLA
may take up to 5–6 years to resorb completely) they are
more tolerated by the organism. Of course it is quite
arguable if something that will remain for such a long
time in the organism will ever be resorbed and if it
should be considered as a resorbable implant. However,
it is clear that the more amorphous PDLLA resorbs
over 2–3 years and the liberated crystallites could induce
an inﬂammatory response [117]. This well known
inﬂammatory response, and the typical pH drop asso-
ciated with PLA and PGA implants is one of its major
drawbacks. These materials are still the gold standard in
applications of biodegradables in medicine, but this
drawback may hinder their increased use in applications
such as tissue engineering scaﬀolding. In addition, it
was shown that the surface morphology or the wett-
ability in PLLA ﬁlms could inﬂuence the inﬂammatory
response [153], and typically cells do not attach well to
PLA and PGA based materials. A fairly complete revi-
sion of the inﬂammatory reaction in animals and
humans upon a number of materials can be found in ref.
[117].
SR composites can be used in a variety of applica-
tions, such as in bioabsorbable ﬁxation in fracture
treatment or in other orthopaedic surgery ﬁxations.
They have been used since 1985 and the number of
operations with such materials has exceeded 300 000
[152]. One can use such systems in glenoidal rim frac-
tures, fractures of the proximal and medial condyle of
the humerus, fractures of the lateral humeral, femoral
and tibial condyle, fractures of the olecranon, radial
head and distal radius, fractures of the hand, metartar-
sal bones and phalanges of the toes, fractures of the
femoral head and neck, fractures of the patella anddisplaced ankle fractures [117,152,154]. Other examples
of the use of bioabsorbable ﬁxation of bone in osteo-
tomies, arthrodesease and other reconstructive surgeries
can be found in the review by Rokkanen et al., which
included applications in orthopaedic surgery and
traumatology in children [152].
These bioabsorbable implants have the advantage to
be able to be combined with drugs or other active sub-
stances that facilitate or accelerate tissue healing and
they have themselves osteostimulatory eﬀect. They oﬀer
thus considerable advantages to be used in arthroscopi-
cal and other minimum-invasive surgical techniques
[152]. Nevertheless the low water-uptake of this type of
polymers does not allow for using swelling as a para-
meter on the design and tailoring of the release proﬁles
of bioactive agents from these materials.
3.1.3. Poly("-caprolactone)
Poly(e-caprolactone) (PCL) is also a semicrystalline
aliphatic polyester, highly compatible with osteoblasts
[155]. PCL exhibit high crystallinity and is highly
hydrophobic, thus having lower biodegradation in vivo
than PLA [156]; therefore PCL is an interesting material
for application requiring long degradation times. As for
the other mentioned polyesters, the degradation in vivo
of PCL also involves random hydrolytic chain scission
of the ester linkages. Despite the modest mechanical
properties (tensile modulus of 200–440 MPa and tensile
strength of 20–42 MPa), PCL has been used in diﬀerent
biomedical application, such as in scaﬀolds for tissue
engineering of bone and cartilage [157]. To improve the
mechanical properties, PCL has been blended or copo-
lymerised with other polymers, such as PLA or PLGA
[158–160]. Due to the relatively low melting point, PCL
may be easily processed by conventional procedures.
Therefore, PCL may be easily ﬁlled with stiﬀer materials
(particles or ﬁbres) and processed by melting techni-
ques. Again the major drawbacks of these materials are
its too slow degradation in-vivo, and the poor cell
adhesion and proliferation on their surfaces, which
combined limit their biomedical applications.
3.1.4. PolyactiveTM
PolyactiveTM is the trade name of a biocompatible
block copolymer composed by a soft, amorphous,
hydrophilic, poly(ethylene glycol), PEG, and hard,
semicrystalline, hydrophobic poly(butylene ter-
ephthalate), PBT [161]. Some years ago it has been
claimed [162,163] that if the weigh ratio of PEG/PBT is
higher than 55/45, the material has bone bonding ability
and is simultaneously biodegradable. Unfortunately, for
such ratios the copolymer has poor mechanical proper-
ties. However, other authors stated later on that such
copolymer is not, in fact, osteoconductive (e.g. [164]).
Even the investigators that originally developed such
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of the copolymer with a bone-like apatite layer [165]
would be needed for the polymer to disclose an in-vivo
bone bonding behaviour.
The inclusion of hydroxyapatite (HA) particles has
been shown to be an interesting way to improve stiﬀ-
ness, oﬀering at the same time an enhancement of
osteoconductivity. Interfacial bonding between HA and
the copolymer may be induced by using polyelectrolydes
on the HA particles, such as polyacrylic acid and
poly(ethylene-co-maleic acid) [166,167]. The coupling of
polyactiveTM on the surface of the HA particles could
also be improve via hexamethylene diisocyanate [168]. It
was found that both tensile strength and Young’s mod-
ulus could be signiﬁcantly improved by the introduction
of such chemical linkage. Besides PolyactiveTM, other
polyether-polyester block copolymers have been pro-
duced. An interesting example is the PEG/PLA copoly-
mer, which have been reported in the literature (see for
example ref. [169]).
3.1.5. Bioactive composites
There are several advantages in incorporating bioac-
tive ceramics into biodegradable polymers, in order to
produce hybrid materials. As for non-degradable poly-
meric matrix composites, calcium phosphate particles,
such as hydroxyapatite (HA) or tricalcium phosphate
(TCP), would improve osteoconductivity and bone
bonding properties [170]. Furthermore, the biocompat-
ibility could be enhanced as the ceramic particles that
induce an increased initial ﬂash spread of serum pro-
teins compared to the more hydrophobic polymer sur-
faces [157]. Additionally, foreign body reaction due to
the release of acidic degradation products could be also
minimised by the buﬀering eﬀect of the basic resorption
products of HA or TCP [171,172]; the ceramic can act
as hydrolysis barrier, delaying the degradation of the
polymer [173]. The auto-generated increase of local
acidity due to degradation, for example, of PLA could
enhance solubility of the ceramic that could be used in
new bone formation [174].
The most currently studied bioactive degradable
composites are obtained by combination of poly(a-
hydroxy esters) and HA; combinations with PCL were
also proposed [175]. For completely absorbable bioac-
tive implants one should use bioresobable ceramics such
has non-sintered HA, tetracalcium, octacalcium phos-
phate and especially TCP [176–178]. A ceramic used to
reinforce polylactides with a three- or fourfold higher in
vitro solubility than a-TCP should be mentioned in this
context [179,180]. The obtained composites presented
suitable degradation characteristics and interesting
mechanical properties, in the range of cancellous bone.
It was shown that the spread of attached human
osteoblasts onto PLA and PCL ﬁlms reinforced with
sintered and non-sintered HA is higher than for the
polymers alone [181]. Also in that work, biochemicalassays relating cell activity to DNA content allowed to
conclude that cell activity is also more intense for the
composite ﬁlms. Cell culture tests on a composite of
TCP and a polylactide were also reported [176]. Also in
this case, the composite showed no cytotoxicity and
evidenced good cell attachment to its surface.
The poly(a-hydroxy esters)/HA composites are
mainly prepared by incorporating the ceramic into a
polymeric solution. The gels suspensions of HA, which
may easily exhibit good dispersion of particles, may
then be dried under vacuum. The resulting solid com-
posite may be shaped using diﬀerent processing techni-
ques. One can also obtain the composites by mixing HA
particles with l-lactide prior the polymerisation [173].
An interesting list of references assigned to the diﬀerent
ways of preparing such composites may be found in a
work of Durucan and Brown [182]. Nevertheless, it
should not be forgotten that typically non melt based
routes lead to the development of systems with lower
mechanical performance and many times require the use
of toxic solvents and intensive hand labour.
One of the PLA/HA composites showing highest
mechanical properties was developed by Shikinami and
Okuno [183]. The initial bending strength of 280 MPa
exceeds the bending strength of cortical bone (120–210
MPa); this strength could be maintained above 200
MPa up to 25 weeks in phosphate-buﬀered saline solu-
tion. Moreover, the modulus could reach 12 GPa [183],
one of the highest stiﬀnesses reported in bioactive poly-
mers. Such composites were obtained from precipitation
of a PLLA/dichloromethane solution, where small
granules of uniformly distributed unsintered HA
microparticles (average size of 3 mm) can be obtained
[183]. Unfortunately the authors do not give many
details on both the extrusion and compression moulding
processing of the material. Moreover, it would be also
interesting to try to develop such kind of biodegradable
materials using melt based processing techniques, that
may prevent the use of solvents, with possible toxic
eﬀects and will eventually generate systems with a better
mechanical performance. It was suggested that PLLA
pieces alone requires a period of time to achieve the
possibility of hydrolysis into the inner core; however,
for the composites, the samples could be ﬁlled quickly
with water and homogeneous hydrolysis could proceed.
More complete tests on the biodegradation of the HA/
PLLA composite rods in subcutis and the medullary
cavities of rabbits were investigated mechanically and
histologically [184]. The degradation was found to be
faster for the case of using uncalcinated HA instead of
calcinated particles.
The non-inﬂamatory response of the tissues pointed
out for the bioactive behaviour of the implants [184]. In
fact, in a more detailed study, it was found new bone
formation at 2 weeks after implantation, especially for
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work, direct bone contact with the composites, without
intervening ﬁbrous tissue, was detected by SEM.
Another work [186] gave further indications for the
bone bonding capability of such composites, where the
loads required to detach plates ﬁxed on the surface of
the bilateral tibial cortices in rabbits were measured at
4, 8 and 25 weeks after implantation. For any implan-
tation time, the bonding strengths in the composites
were always greater than for the pure PLLA implants.
In this context, the bioactive character of the compo-
sites was also veriﬁed by the formation of HA onto their
surfaces after 7 days of immersion in simulated body
ﬂuid [183]. It should also be referred herein that bone-
like apatite layers could be deposited on PLA ﬁbres
from a biomimetic process [187]. In that case, the ﬁbres
should be previously immersed in a simulated body ﬂuid
with ion concentrations nearly 1.5 times of those in the
human blood plasma.
A good strategy to improve even more the mechanical
properties of bioabsorbable materials could be the
combination of previously oriented polymeric ﬁbres
with the ceramic particles. Materials based on the con-
cept of self-reinforcement, using polylactides, with the
addition of TCP or HA were studied using conventional
mechanical testing [188] and dynamic mechanical ana-
lysis [189]. Typically, the ﬂexural modulus increased
from 6.5 GPa, for the case of pure polymer, to 7–8
GPa for the case of the composites. On the other hand,
the ﬂexural yield stress increased from 65 MPa, for
the unﬁlled material, to 70–80 MPa, for the 70% by
weight HA content composite, and 80–100 MPa, for the
70% by weight TCP composite. We can thus conclude
that at this point these composites exhibit less mechan-
ical performance than the bioactive composites devel-
oped by Shikinami and Okuno [183]. However, the
concept of combining self-reinforcement and ceramics
seems to have great potential and there are certainly
technical aspects related with the composition and the
processing that could be improved.
An important aspect that should also be addressed in
more detail is the interfacial properties between the
ceramic and the matrix phases. It also appears that this
issue has been neglected in the context of absorbable
composite despite a lot of eﬀort has been done in the
enhancement of the interfacial adhesion in conventional
polymer matrix composites (e.g. [56,57,190]). A recent
study pointed out for the importance of measuring the
ﬁbre-PLLA matrix interface adhesion using both
microbond and fragmentation methods [191]. Fibres of
carbon, absorbable calcium carbonate, PGA and chitin
were used. This study included the monitoring of the
interface performance during in vitro hydrolysis. The
importance of the chemical treatment of the CFs in
polylactide composites has been investigated by looking
at their mechanical properties, including the study of
the inﬂuence of the in-vitro degradation [192,193]. Suchkind of studies should be, in the authors’ opinion,
carefully extended to ceramic/polylactides composites.
The discussion up to now has been mainly devoted to
the development of compact composites. However,
porous bioabsorbable materials have gained increasing
interest, especially in the area of tissue engineering [194].
High porous, synthetic, three-dimensional scaﬀolds can
serve as the growth substrate for osteoblasts or osteo-
progenitor cells. In fact, polylactides have been studied
as scaﬀold materials for applications in bone tissue
engineering [195]. However, there is a need for enhan-
cing the mechanical properties of such systems. There-
fore, porous composite materials of polylactide/HA
have been proposed to overcome this problem, increas-
ing also the osteoconductivity of the scaﬀolds [196–198].
These scaﬀolds could improve, for example, the bulk
penetration of osteoblasts into the inner pores, where in
pure PLLA scaﬀolds the osteoblast attached primarily
on the outer surface of the foam [197]. Also the number
of cells was always higher in the composite scaﬀolds
during 6 weeks of in vitro cultivation [197]. It is clear
from these studies that also in the area of bone tissue
engineering bioactive composite systems oﬀer in many
cases better properties than those of pure polymeric
materials.
3.2. Starch based degradable polymers as an example of
natural origin systems
Biopolymers are an important source of materials
with a high chemical versatility and with high potential
to be used in a range of biomedical applications. Many
of them are readily available and their properties may
be easily changed by diﬀerent physical and chemical
methods. This enables tailoring of important properties
such as the water-uptake capability, degradation kinet-
ics or the mechanical properties that will target the
desired speciﬁcations for a given application. Natural
based materials are also usually biocompatible and non-
cytotoxic due to their similarity with living tissues.
A great number of diﬀerent natural based materials
have been studied and proposed for diﬀerent biomedical
uses, namely polysaccharides (starch, alginate, chitin/
chitosan) or proteins (soy, collagen, ﬁbrin gels) and, as
reinforcement, a variety of bioﬁbres such as lig-
nocellulosic natural ﬁbres. Good reviews have described
the properties of such systems (e.g. [116,199]), and this
would be beyond the scope of this review. In this review
we will be discussing only starch based polymers, as an
example of natural origin polymeric matrix composites
that have been proposed for biomedical applications.
Such systems have been emerging recently as candidates
for being used in diﬀerent applications, such as in scaf-
folding for the tissue engineering of bone and cartilage,
materials for bone ﬁxation and replacement as well as
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of drugs and other bioactive agents, and new hydrogels
and partially degradable bone cements.
3.2.1. Starch and starch based materials
Starch designates the major polysaccharide con-
stituent of photosynthetic tissues and of many storage
organs in plants. Starch consists of a mixture of amylose,
a linear macromolecule consisting of a-(1!4)-glucan,
with amylopectin, a highly branchedmacromolecule that
consists of a a-(1>6)-glucan with a-(1!6) linkages at
the branch points [200–202]. In vegetables, starch is
produced in the form of granules that can vary in terms
of size and composition [200,201,203]. In plants, starch
is found as semicrystalline granules, containing both
crystalline and amorphous domains, in three main
overall crystalline variants: A (cereal), B (tuber) and C
(smooth pea) [202]. The semicrystalline starch can be
disrupted by extrusion technology with the appropriate
combination of shear, temperature and plasticizers
[202], in a process designated as gelatinisation. Gelati-
nisation is also achieved by low temperature methods
based on the use of solvents [204].
Within the plastics technology ﬁeld, starch or starch
based plastics have been studied as biodegradable or
partially biodegradable materials for replacing and
decreasing the environmental impact of traditional
commodity plastic materials [202,205,206]. Several
studies [207–215] described the processing and/or the
properties of starch materials containing plasticizers,
designated as thermoplastic starch (TPS). Although
conventional processing routes such as extrusion or
injection moulding can be used for these materials, the
associated thermo-mechanical environment induces
structural modiﬁcation and eventual degradation of the
starch [216–220]. Various works reported the develop-
ment of mixtures of starch with other polymers such as
cellulose acetate (CA) [221], PCL [222,223], ethylene
vinyl alcohol copolymer [224–231], ethylene-vinyl ace-
tate copolymer [232–235] and low density polyethylene
(LDPE) [236–239]. Several starch based blends are
commercially available under the tradenames Mater-Bi
and Bioplast, from Novamont (Italy) and Biotec
(Germany) respectively [221,240], among many others.
3.2.2. Starch as Biomaterial
Starch-based polymers present an enormous potential
to be widely used in the biomedical ﬁeld, as these nat-
ural polymers are totally biodegradable and inexpensive
when compared to other biodegradable polymers avail-
able [203,207]. Reis et al. [241] proposed the blends of
starch with (1) ethylene vinyl alcohol copolymer (desig-
nated as SEVA-C), (2) cellulose acetate (SCA), (3)
polycrapolactone (SPCL) and (4) poly(lactic acid)
(SPLA) as potential alternative biodegradable materials
for a wide range of biomedical applications [241–263].
These blends exhibit a bioactive behaviour by means ofadequate ceramic loading with ﬁllers such as HA [241–
246] and bioactive glasses [248,249], or by means of
biomimetic routes [250] coupled with a degradation
behaviour when immersed in simulated physiological
media [251–253]. These materials exhibit a biocompa-
tible behaviour demonstrated by several in vitro [255–
257] and in vivo studies [257]. These characteristics jus-
tiﬁed their study for a broad range of applications such
as bone ﬁxation/replacement applications [242–249],
bone cements [258,259], drug delivery devices [260,261]
and tissue engineering scaﬀolds [255,262,263].
3.2.3. Structure development of starch based blends
The consideration of starch based systems as potential
biodegradable biomaterials for tissue replacement/ﬁx-
ation, or as tissue engineering scaﬀolds to be applied in
load-bearing sites demands a compatible mechanical
performance with human bone, i.e. a bone-matching
mechanical performance. The research approach to
develop such mechanical behaviour in compact starch
based materials relied on two approaches: (1) the com-
bination of the biodegradable system with a bioactive
reinforcement and (2) the inducement of a deliberately
orientated morphology during the respective processing
operation [241–247]. The use of non-conventional pro-
cessing techniques on SEVA-C and SEVA-C/HA com-
posites was studied by Reis et al [241–244] that reported
an enhancement of the mechanical properties following
application of shear controlled orientation in injection
moulding (SCORIM). The combined use of twin-screw
extrusion (TSE) in the compounding stage and of
SCORIM in the moulding process allowed for the
development of starch based composites with an
induced structural orientation and high mechanical
performance [241–244]. The improvements in mechan-
ical performance observed with SCORIM application
were attributed to the solidiﬁcation of the polymer
under a controlled macroscopic shear ﬁeld that induces
orientation of the molecular structure. This has been
observed for starch based materials in a study [247]
focussing on the SCORIM processing of SEVA-C,
where the solidiﬁcation of the polymer in an extended
state, as imposed by the shear ﬁeld applied during
SCORIM was observed to increase molecular orienta-
tion, crystallinity and consequently the stiﬀness and
strength of SEVA-C.
3.2.4. Inﬂuence of bioactive ﬁllers
The incorporation of bioactive ﬁllers such as HA
[243–246] or bioactive glasses [248,249] in SEVA-C aims
to assure the bioactive behaviour of the implant and to
provide the necessary stiﬀness within the typical range
of human cortical bone properties. For SEVA-C, the
increase in HA content leads to a desirable increase in
stiﬀness [244–246]. Maximum values of stiﬀness above 7
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weight [244]. However, the reinforcement of SEVA-C
with particles such as HA aﬀects the typical rheological
behaviour of the blend, which demands for a careful
optimisation of the processing parameters during injec-
tion moulding [247]. For composites ﬁlled with bioac-
tive glass particles, the mechanical performance was
also shown to be dependent on bioactive glass contents
[248]. Values of 3.5 GPa and 51 MPa were reported
respectively for tensile modulus and strength for com-
posites of SEVA-C ﬁlled with only 10% by weight Bio-
glass1 particles [249]. Bioactivity tests have shown that
the reinforcement with bioactive ﬁllers such as Bio-
glass1 or HA particles is eﬃcient to assure the desired
bioactive behaviour of the composite [246,249]. How-
ever, the eﬃciency of the two ﬁllers is considerably dif-
ferent. SEVA-C/Bioglass1 composites displays a
bioactive behaviour above 10% weight Bioglass1 [249],
while the same behaviour is only observed, in the case of
SEVA-C/HA composites, for 30% weight [246]. In any
case the required ﬁller amount is much less than it has
been reported for other systems that are not capable of
up-taking water.
3.2.5. Degradation behaviour and biocompatibility of
starch based blends
The blends of starch with ethylene vinyl alcohol
copolymer (SEVA) when immersed in a simulated
physiological solution exhibit two modes of degradation
behaviours [242]: a weight loss associated to the leach-
ing of plasticizer and other low molecular weight addi-
tives and a weight loss associated to the intrinsic
chemical degradation of the polymer. These polymers
are also enzimatically degraded [242] in the presence of
a-amylase that can be found in human saliva, blood or
pancreas. For SEVA-C, the degradation behaviour evi-
dences a dependence on the molecular weight of the
blend, being more pronounced for lower molecular
weight materials [242]. The leaching of plasticizer and
other processing additives occurs in two stages, the ﬁrst
stage occurs for times of immersion between 0 and 6
days [253], which causes a steep decrease in sample
weight, and a second stage for times of immersion
between 6 and 15 days, for which the weight loss levels
oﬀ. The enzymatic degradation takes place more pro-
minently in a third stage, becoming evident for times of
immersion above 15 days [253]. The typical ﬁnal degra-
dation products are low molecular weight starches,
fructose and maltose. These products are clearly bio-
compatible and do not lead to any inﬂammatory
response. Concerning biocompatibility, SEVA-C and
SEVA-C/HA composites exhibit a non-cytotoxic beha-
viour [256,257], inducing a satisfactory tissue response
when implanted as shown by in-vivo studies [257]. Fur-
thermore, the SEVA-C/HA composites induce a posi-
tive response on osteoblast-like cells to what concerns
cell adhesion and proliferation [256]. Although, SEVA-Cappears to be less cytotoxic than SCA, comparative
studies indicate a better cell adhesion to compact SCA
substrates [256], including porous SCA scaﬀolds [255].
Cytotoxicity tests have shown that the composites of
SCA with HA have a similar response to the one
observed for SCA [256].4. Composite systems non-processable by melt-based
techniques
Although in the previous sections we have shown that
melt-based, polymer matrix composites are being
increasingly accepted as the best alternative for hard
tissue replacement, there are several clinical situations
on which they cannot be used. As an example, injectable
systems may be preferred when the fracture, defect or
hole must be ﬁxed and posses mechanical resistance
immediately, when it is in a position diﬃcult to reach or
has a complex shape or simply because of the ease
handling and implantation of these systems. Moreover,
some materials are not able to be melt processed, either
because their processing temperatures are so high they
would degrade before melting (softening) or because
they are designed to incorporate substances that do not
stand high temperatures (proteins, drugs, etc.); in those
cases alternative methods should be used.
Despite this review paper dealing mainly with poly-
mer-matrix composites, injectable systems presenting
ceramic matrix and the polymer as the dispersed phase
were also chosen to be included in this section for a
couple of reasons: they were developed exactly to mini-
mize some of the disadvantages of polymeric based
bone cements; the matrix in these systems is the same
material used as dispersed phases in some polymer–
matrix composites; and they present properties that
make them more useful for other kind of applications
(diﬀerent than those of their polymer-based counter-
parts). Therefore, their inclusion in this review is aimed
at giving the reader a more complete picture of the dif-
ferent materials, properties and applications (load bear-
ing, non-load bearing) that can be obtained with
injectable composites.
This section then is divided in three parts: (1) inject-
able composite systems with ceramic matrix,; (2) inject-
able composite systems with polymeric matrix; and (3)
composites processed by other techniques.
4.1. Injectable ceramic-based systems
When polymers are incorporated into a ceramic
matrix, the resultant materials combine the ﬂexibility of
polymer fabrication and modiﬁcation with the reinfor-
cing eﬀects and bioactive behaviour of ceramics, being
ideal for hard tissue replacement. They become stronger
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chains on the ceramic crystals. So far, although these
composites present advantages over the monolithic
injectable ceramics, there are yet some drawbacks that
must be overcome.
Calcium phospate cements (CPC) were developed in
the late 1980s [264] and, although being an excellent
alternative to conventional acrylic bone cements in
terms of osteoconductivity (they set inside the body to
form HA) and thermal damage (the setting occurs at or
near body temperature), they are whashed-out due to
their long setting time and to the penetration of body
ﬂuids before setting completely. So, despite the forma-
tion of hydroxyapatite (HA) in vivo during setting of
CPC being attractive as a hard tissue subsitute (since it
occurs at body temperature and pH and without
immune response), the material suﬀers from the same
brittleness problems as the pre-shaped products, being
useful only for space-ﬁlling. To solve these problems,
useful alternatives are fast setting CPC (which sets much
faster than conventional CPC materials) and the pre-
paration of composite cements by the addition of poly-
meric viscous gels (which reduce the liquid penetration
to the cement paste) into the liquid component of the
cements [265,266]. The combination of both approaches
is being increasingly studied, as will be shown in the
next paragraphs.
TenHuisen and Brown [267] studied the eﬀects of
gelatin on the kinetics of HA formation and on the
microstructure of HA which is formed. The eﬀect on the
rate of formation, on the solution chemistry and in the
microstructure of the composite compared to the pure
CPC was negligible. The only observed diﬀerence was
the presence of gelatin interconnecting the HA clusters.
However, the composites were produced without mixing
of the components, only addition of the gelatin solution
on the solids, what is a very diﬀerent condition when
compared to the intense mixing occurring during CPC
composite preparation. And of course the preparation
method could inﬂuence negatively the obtained results.
Sodium alginate (alg) was also proposed as the poly-
mer component [268,269]. While the conventional CPC
(c-CPC), after 1 week of implantation, induced a severe
inﬂammatory response and was completely crumbled,
the so called anti-washout type fast-setting CPC incor-
porating sodium alginate (aw-FSCPC(alg)) showed no
inﬂammatory response and did not crumble; one expla-
nation was the fast rate of HA formation in the latter
cement [270]. This phenomenom would additionaly
result in higher mechanical properties since the initial
stages after implantation.
Later the interest moved to chitosan(chi), because it has
more pharmacological beneﬁts for bone formation than
the alginate [271]. The authors studied the soft tissue
response to aw-FSCPC(chi) and tried to understand the
origins of the good response to CPC, by using diﬀerent
organic compounds [266]. In spite of the fast transforma-tion to apatite being claimed as the origin of the good
tissue response to these cements, they showed, by com-
parison with composite cements with citric and acrylic
acids, that the dominant role was played by the fast
setting (that is, high initial mechanical strength). How-
ever, this is a necessary, but not suﬃcient, condition for
this behaviour.
When implanted in tibia, the composite was sur-
rounded by thin ﬁbrous tissue, while particles of the c-
CPC were scattered and surrounded by foreign body
reaction giant cells [265]. These results agreed with pre-
vious ones obtained by the same group where severe
inﬂammatory response 1 week after subcutaneous
implantation was found only for c-CPC, not for the
composite with alginate [272]. However, although aw-
FSCPC(chi) showed better soft tissue response, it did
not promote bone formation when compared to c-CPC.
One possible reason could be the very low amounts of
chitosan used (approximately 0.14%), what could not
have suﬃcient pharmacological eﬀect to regenerate
bone. Mickiewicz et al. [273] also prepared composites
of CPC incorporating diﬀerent water soluble polymers
(polyelectrolytes, proteins and neutral polymers). The
polymers that did not promote any improvements in
mechanical properties, and did not change the mor-
phology of the cement, only induced a crystal growth
relative to the pure cement. On the other hand, those
who did increase compressive strength gave rise to
nanocrystalline agglomerates, smaller and more inter-
penetrated than the other composites, which could
explain their improved properties. However, the solid/
liquid ratio was not kept constant for the diﬀerent for-
mulations, and this parameter is known to play an
important role in the mechanical properties. And,
although the compressive strength was found to
increase up to six times, the best systems presented set-
ting times 30 to 230% higher than the commercial
cement, what is also an important point to consider
regarding injectable systems.
Fujishiro et al. [274] also developed a CPC/gelatin gel
composite (since this gel possesses good cell aﬃnity and
forms a viscous gel with water). Indeed, the addition of
the gel confered stability to the composite in simulated
ﬂuids, increased the compressive strength (up to 5% of
gelatin gel) and promoted a time dependence of com-
pressive strength similar (but with values always higher)
to the cement without gel.
Daculsi et al. [275,276] developed a composite inject-
able bone substitute (IBS) based on biphasic calcium
phosphate, BCP (60% HA+40% b-TCP), and 2%
aqueous solution of methylhydroxypropyl cellulose
(MHPC) that hardens in situ and was said to be per-
fectly biocompatible, resorbable and easy to ﬁt bone
defects (due to their initial plasticity). They found that
the best ratio BCP/solution was 65/35. Regarding cyto-
toxicity, although direct-contact assays showed no804 J.F. Mano et al. / Composites Science and Technology 64 (2004) 789–817
diﬀerences among the composite, its components and
the control, the extracts of the composite or BCP
showed inhibition of cell proliferation. Anyway, bone
ingrowth was observed at the same time resorption of
calcium phosphate ceramic occurred.
Later, they studied the interactions between the two
phases. After mixing, there was a decrease in the mean
diameter of BCP granules, and this inﬂuenced the visc-
osity of the paste [277,278]. They found dissolution of
grain boundaries (specially of those without lattice con-
tinuity) and of b-TCP crystals during interaction of
MHPC and BCP and precipitation of apatitic crystals on
HA crystals surface. Both phenomena were responsible
for the observed granulometry changes [275].
Although the fabrication of injectable ceramic based
composites in most cases improved the mechanical
properties of the system and provided the material with
resistance to ﬂuids penetration, these achievements were
limited by the amount of polymer that can be added to
the paste. Mickiewick et al. [273], for instance, reported
that after a critical concentration (that depended on the
type and molecular weight of the polymer, but was
always around 10%), the polymer started forming a
thick coating on the crystal clusters, preventing them
from interlocking, originating plastic ﬂow and, as a
consequence, decreasing mechanical properties. Fujish-
iro et al. [274] also reported a decrease in mechanical
properties with higher amounts of gel, which was
attributed to the formation of pores due to leaching of
gelatin in solution. Therefore, it seems that mechanical
properties, although improved by the addition of poly-
mers, are still a limitation for the application of ceramic-
based injectable systems in load-bearing sites.
4.2. Injectable polymer based systems
Although polymers oﬀer several advantages over
injectable ceramics, such as easier tailoring of mechan-
ical properties and degradation times [279] and possibi-
lity of functionalization to interact speciﬁcally with
certain cell types (due to the widely varied polymer
chemistry) [280], they yet suﬀer from problems like low
(or no) ability to bond to bone and not enough
mechanical properties for the desired (hard-tissue
replacement) application.
In spite of polymethylmethacrylate (PMMA) based
bone cement being currently the most widely used
polymer-based injectable, biodegradable materials, as in
other biomedical applications, oﬀer several advantages
and, for that reason, are being increasingly studied.
Poly(propylene fumarate) (PPF) has been proposed as a
substitute to PMMA in partially degradable bone
cement [281]. PPF is an unsaturated polyester with
double bonds that can be crosslinked in vivo by diﬀer-
ent monomers [281,282]. Gerhart et al. [281] compared
an experimental biodegradable bone cement (PPF-MMA) with a commercial one in terms of antibiotic
release from the cement and mechanical properties,
ﬁnding that the experimental one achieved and man-
tained considerably higher antibiotic levels for a longer
duration than the commercial one. However, although
the initial mechanical properties of the cements were
good, they decreased by a factor of 12 just 4 weeks after
implantation. To solve that problem, they developed a
composite with TCP and CaCO3 as ﬁllers, which hard-
ens in 24–36 h, had properties much higher than human
trabecular bone and workable enough to be packed in
defects of complex shape [281]. They found that com-
pressive strength and resistance to degradation
increased with increase in MMA concentration. The
calcium dissolved from the composite, although not
directly proportional to degradation time, helped to
keep the pH at higher values (as compared to the con-
trol). Thus, the composite seemed to be compatible with
bone remodeling [283].
Later on, He et al. [284] studied the eﬀect of double
bond ratio and b-TCP content on crosslinking and
mechanical characteristics of PPF-based injectable
composites. The increase in double-bond ratio and/or
the addition of b-TCP resulted in an increase of
mechanical properties. An important advantage of this
system over other polymer-based injectables is the very
low temperature of reaction (crosslinking) which was
always lower than 40 C. However, even with the ﬁller,
the mechanical properties were still too low to be suitable
for bone replacement or cements.
In vitro studies in formulations including also a poro-
gen agent showed that increase in PPF molecular weight
or incorporation of b-TCP increased the mechanical
properties and that the formulations maintained the
minimum requirement for replacement of human trabe-
cular bone during 7 weeks [285]. There are, however, a
threshold molecular weight above which the number of
crosslinked double bonds per PPF chain is independent of
the chain length, therefore the molecular weight does not
aﬀect the compressive properties, but does aﬀect the heat
released during crosslinking and the gel point [286]. Due
to continued crosslinking during immersion in phos-
phate buﬀered saline (PBS), these materials presented
an increase in mechanical properties during the ﬁrst
weeks of implantation, being claimed as the ﬁrst biode-
gradable materials with these properties [287]. After in
vivo implantation no sample were mechanically intact
beyond 3 weeks [288]. The b-TCP concentration altered
greatly the mechanical properties; in fact, without the
ceramic the formulations remained stable for only 1 day.
Histological evaluation showed an initial inﬂamatory
response followed by a formation of thin ﬁbrous capsule
encasing the samples. However, although the material is
claimed to be injectable, it was crosslinked (18 h), UV-
sterilized (1 h) and aged (2 h) at room temperature prior
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Partially degradable polymer–polymer composites
were also produced by the incorporation of up to 23%
by weight of poly(caprolactone) (PCL) in the solid
phase of acrylic-based bone cement formulations [289],
aiming at producing injectable systems for drug delivery
in non- or small-load bearing applications. The vanco-
mycin release was much improved (comparing with a
pure PMMA control) and the lower polymerization
temperature was better for the incorporation of the
drug, but the mechanical properties were negatively
aﬀected by the PCL.
Another partially degradable innovative bone cement
was developed by Reis et al. [259], who used a totally
new approach. They used a natural-origin polymer (a
polymeric blend containing corn starch) as the solid
phase and an hydrogel forming monomer (acrylic
acid—AA) in the liquid phase, together with the MMA
monomer. Due to the ductility of the system, up to 30%
by weight of HA could be added to the solid phase
without deleterious eﬀects on the mechanical properties.
Indeed, signiﬁcant improvements were found in both
tensile and compressive modulus, and, by playing with
the solid/liquid ratio, the tensile and compressive
strengths could also be improved. Moreover, an apatite
layer was formed as early as 7 days of immersion in
simulated body ﬂuid, and this layer thickened with
longer immersion times. The authors concluded that
20% by weight of HA was the optimized amount for
this system. This type of system presents also other
advantages. It is partially degradable, allowing for bone
ingrowth into the degradable phase original location
facilitating the ﬁxation of the prosthesis due to an
interlocking eﬀect. Also the water-uptake capability of
these bone cements facilitates the release of antibiotics
or other bioactive agents incorporated on the bone
cement, being simultaneously less aggressive to the sur-
rounding tissues. Finally nothing is changed on the
concept and application of the cement, which helps on
introducing it into clinical practice.
As the several alternatives (partially or fully degrad-
able polymers, injectable ceramics) did not yet present
properties that make them suitable for being used as
bone cements, the inert acrylic-based systems continue
to be the best formulation. But, due to their lack of
fatigue resistance and bioactivity, the incorporation of
ﬁllers (specially bioactive ﬁllers) seemed to be an appeal-
ing approach to improve their behaviour. Several authors
[290,291] incorporated bioactive particles in bone cement,
but the results were not satisfactory due to deterioration
of mechanical properties after adding a large amount of
the particles or lack of bioactivity when the amount was
low. Sogal and Hulbert [290] added HA to two commer-
cial bone cements and found that the ultimate tensile
strength decreased even for small ﬁller loadings (10%).
A group from University of Kyoto has been deeply
involved in studying novel formulations with bioactiveparticles. They incorporated apatite–wollastonite (AW)
glasses (AWG) and glass–ceramics (AWGC), glass
beads (GB) and HA on bisphenol-a-glycidyl methacry-
late-based resin (Bis-GMA), and explained the bioac-
tivity of their systems in the following way [292]: there is
a formation of an uncured surface layer (due to inhibi-
tion of polimerization by oxygen) that results in unco-
vering naked bioactive powders on the surface; these
incompletely polimerized oligomers are leached from
the surface and the exposed bioactive ﬁller allows the
formation of a dense and uniform apatite layer, due to
its high bioactivity.
The interfacial failure load (on the cement–bone
interface) was found to be in the order abra-
ded>uncured>>cured surfaces [293]. At both abraded
and uncured surfaces the bioactive particles are exposed
to the bone, but in the second case the interface is
weaker, proably due to leaching of unpolimerized
monomer.
Because of this mechanically weak interface, they
developed a novel formulation consisting of bioactive
ﬁllers (AWGC, GB, HA), PMMA powder and MMA
resin [294]. This PMMA-based cement is advantageous
over the bis-GMA one because it raises less concerns
regarding the compatibility issue and has less residual
monomer after polymerization. The materials contain-
ing GB had better mechanical properties than the others
(because of the smaller spherical shape and the glassy
phase that resulted in good silane treatment) and higher
bioactivity. Besides, they decreased the maximum tem-
perature of polymerization (Tmax) and the residual
monomer content.
Shinzato et al. [295] showed that the compressive
strength, the bending modulus and the aﬃnity index (a
measure of the length of bone in direct contact with
cement) increased with increase in the glass beads up to
70% by weight. This high loading did not cause dele-
terious eﬀects on the handling properties of the cement.
After soaking in water at 75 C for 5 days, bone
cements with less than 0.2% of silane coupling agent
had better mechanical properties; the same behaviour
was observed in the aﬃnity index of implanted speci-
mens. This was attributed to the fact that a monolayer
of the silane coupling agent formed around the glass
beads when its concentratin was 0.2%; with thicker
layers (higher concentrations of the agent) the ion
transport (necessary for bone formation) was dis-
favored, leading to lower osteoconductivities [296].
The particle size of GB was also studied [297]. As the
smaller ones have a larger surface area, this may help
expose more bioactive surface on the surface of the
cement, creating more contact with the bone. The
mechanical properties also increased with decreasing
particle size due to improvement of ﬁlling eﬀect. How-
ever, as small particles may cause strong foreign body
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from the bone cement surface. As they found degrada-
tion of glass beads due to increased ﬁller loading, the
use of small beads also could be advantageous since it is
possible to reduce the load while keeping the mechanical
properties and osteoconductivity.
When implanted in sites exposed to mechanical stress,
the cement still bonded to bone, but the aﬃnity index
was lower than for the cement in non-load bearing
conditions, probably due to micromotion between
cement and bone at the interface [298].
Mousa et al. [299] added AWGC to several commer-
cial bone cements and also prepared a novel formula-
tion. The commercial bone cements with the ceramic
had improved mechanical properties over the conven-
tional ones, but the best formulation was the one with
intermediate molecular weight of the PMMA powder
and smaller particle size.
This extensive work performed by the group of
Kokubo [292–299] originated a composite cement with
excellent mechanical properties, osteoconductivity and
handling properties suitable to be used as injectable
materials. However, the very high loadings suggested
(70% by weight) for an already brittle material
increased the fracture toughness and the stiﬀness at the
cost of decreasing the ductility, what could not guaran-
tee a good performance of this bone cement. Moreover,
this much higher modulus, when compared to the con-
ventional bone cement, brings a negative eﬀect: the
stress shielding of bone, leading to bone resorption that
was also caused by the increase in the intraosseous
pressure after implantation [298]. In conventional
PMMA cement, the soft tissue layer formed between it
and the bone due to its lack of osteoconductivity may
have alleviated this congestion, so that no bone resorp-
tion was observed. A ﬁnal remark should be made
regarding the lack of measurements of mechanical
properties in the long-term (mainly fatigue resistance).
It has already been shown that the addition of ﬁller such
as HA, although positively aﬀecting the ﬂexural
strength and modulus, reduced the number of cycles to
failure in fatigue tests [300]. An alternative to increase
the fatigue resistance of bone cements is by the using of
ﬁbres such as titanium ﬁbres, which were shown to
increase both the number of cycles to failure [301] and
the fracture toughness of notched specimens [302]. The
reinforcing eﬀect of the ﬁbres increased with decreasing
stress intensity and were further improved by the use of
centrifugation, showing an additive eﬀect between these
two treatments [301]. However, the addition of ﬁbres is
even more limited than the addition of particles, since
they severely decrease the handling and ﬂow of the paste
[291,302].
HA was studied as a ﬁller for improving bioactivity
and mechanical properties by other authors, also pre-
senting good results. This ceramic is a well-known bio-
compatible, osteoconductive and osteophilic material[291,303]. These are due to the chemical similarity of the
synthetic HA with the one present in the bone and to
the high chemical reactivity of its surface, both char-
acteristics resulting in its ability to strongly bond to
bone (osteoconductivity). This behaviour makes the
material very advantageous to be used in hard-tissue
replacement composites. However, due to the brittleness
of the HA and to the lack of interaction with polymer
(if no coupling agent is used), the ﬁller may present
deleterious eﬀects on the mechanical properties (when
added at high loadings). Therefore only limited
amounts of HA can be incorporated into PMMA bone
cement. And, as the proportion which can be included
while maintaining mechanical strength or handling
properties are small, the increase in bioactivity (provided
by the ceramic) is not likely to be very large [291].
Therefore, alternatives like eﬃcient ways to bond HA to
the matrix or the development of new matrix systems are
being studied, as it will be shown in the next paragraphs.
Dalby et al. [304] studied the eﬀects of the incor-
poration of only 17.5% by weight of HA into PMMA:
besides providing higher levels of human osteoblast-like
cells (HOB) proliferation and phenotype expression,
exposed HA particles served as preferential anchoring
of HOB cells and either were entrapped by these cells or
induced them to produce cristalline particles. In another
study [305], the authors demonstrated that, although
both conventional and composite bone cements were
able to support normal osteoblast cell growth, full con-
ﬂuence was achieved earlier (7 days) on the PMMA/HA
cement, while polymer was still visible through the cell
layer on the plain cement. But this increase in biological
properties did not result in an increase of mechanical
strength, and a balance point between the two should be
found.
Similar biological behaviour was found by Moursi
and colleagues [306] when studying PMMA with 20%
by weight HA. After 8 days of osteoblast cell culture,
proliferation on the composite was signiﬁcantly higher
than on PMMA and the osteoblasts showed a more
distinct networked pattern of organized ﬁbronectin.
However, in this study the increase in mechanical prop-
erties was found, with the three-point bending strength
almost doubling. Vallo and coworkers [303] also found
increase in fracture toughness and ﬂexural modulus
with up to 15% by weight of HA in a commercial bone
cement. However, the best combination of mechanical
properties with workability of the paste was obtained
with addition of about 3% of the ceramic.
Working with the PEMA/n-BMA (n-butyl
methacrylate) system, which presents the advantage of
being much more ductile than conventional PMMA
bone cement, Harper et al. [300,307] could add up to
40% by weight HA without a decrease in static mechan-
ical strength. After immersion in Ringer´s solution, the
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properties were signiﬁcantly reduced. The decrease in
fatigue resistance due to HA was compensated for
(when tested in air) by the use of a silane coupling
agent; however, after immersion in the saline solution
the resistance was considerable lowered. This implied
that the silane coupling agent was not as eﬀective in the
presence of Ringer’s solution, due to either dissolution
or hydrolysis of the coupling agent in the presence of
water and/or the mineral salts. Similarly, Dupraz et al.
[308], reported that only about 50% (in the best situa-
tions) of these coatings remained after 5 days of water
extraction at 37 C; primary and secondary amines were
completely removed.
An alternative to improve the interaction ﬁller–matrix
is the addition of adhesion promoting agents, which
also promote bonding of the cement to the bone and/or
the prosthesis. Morita et al. [309], with incorporation of
4-methacryloyloxyethyl trimellitate anhydride, pro-
moted adhesion of the polymer to HA, preventing the
weakening associated with the introduction of this ﬁller
and decreasing the water uptake. After implantation,
the normal cement presented adhesive failure at the
interface between it and bone, while with the use of the
adhesive cement there was a cohesive fracture of the
bone. Shinzato et al. [310] added phosphoric ester
(another adhesion-promoting agent) to the liquid com-
ponent of the formulation. The strength increased,
probably due to the eﬀects of copolimerization, the
same occurring with the aﬃnity index.
Another methodology for bonding HA to PMMA
was tried by Liu et al. [311,312] who after showing the
ability of HA to react with organic isocyanate groups
grafted acrylic polymers on these modiﬁed HA. Ther-
mogravimetric and infrared analysis demonstrated that
the polymers were chemically bonded to the particles
through the isocyanate groups, making it a suitable
approach to improve the adhesion matrix-ﬁller.
4.3. Non melt-processable composites
Although melt-processing methods are usually pre-
ferrable because they do not demand the use of solvents
that may be toxic and necessitate additional recovery
steps to reduce solvent emission, other alternatives may
be chosen for materials that degrade/decompose before
melting [313]. Suitable alternatives are solution-based or
precipitation methods, which allow for the preparation
of composites of polymeric matrices and HA with
enhanced osteogenic potential (provided by the HA),
prevention of HA migration (due to the binding action
of the polymer matrix) and suﬃcient mechanical prop-
erties for orthopaedic use. However, some of the tech-
niques reported (mixing of HA powder in a polymer
solution or coating of HA particles onto a polymer
sheet, among others) gave origin to macroscopically
inhomogeneous composites without enough mechanicalproperties and that often caused inﬂammation after
implantation [314]. The coating of HA onto a chitosan
ﬁlm by a biomimetic method, for instance, [315], although
turning the material more suitable to bond to bone, is not
expected to increase the mechanical properties of the
polymer.
However, in the case of compact and stiﬀ materials,
this methodology (coating) can be very useful when
used as a way to improve the bioactivity of several kinds
of polymers and even metals. Leonor and Reis [316]
have developed an auto-catalytic deposition methodol-
ogy to produce calcium–phosphate layers onto the sur-
face of polymeric biomaterials (starch-based blends and
HMWPE): prior to in vitro tests, specimens were
immersed in either alkaline or acid baths (with con-
trolled pH and temperature). After only 1 h of immer-
sion the specimens have already developed a calcium–
phosphate layer (which became more compact and
dense after immersion in simulated body ﬂuid—SBF),
which was a considerably improvement compared to the
6–24 h of induction time needed by the biomimetic
coatings [317]. Another methodology was developed by
Oliveira and Reis [318,319] using a sodium silicate gel
for impregnation of compact and porous specimens of
starch-based blends during 24 h in a controlled atmo-
sphere. This impregnation could or not be preceded by
pre-incubation in a calcium chloride supersaturated
solution (because the calcium ions increase the apatite-
forming ability of a silica layer [320]). With these treat-
ments, a clear apatite-like layer was observed after only
6 h of immersion in SBF, and the layer could be
observed even inside the pores (what is not easy to get
with standard biomimetic coatings). Although no
mechanical characterization was reported, the coating
would provide fast bonding with the surrounding bone,
in this way improving the mechanical performance of
the interface implant–bone and of the whole construct.
Wan et al. [313] developed a new solution-based
method to incorporate HA in chitin solutions in which
the ceramic particles were uniformly dispersed and ori-
ginated an intimately blended material with no sedi-
mentation/aggregation. However, as usual with non-
melt processed materials, it was diﬃcult to obtain uni-
form dimensions, especially for the specimens with
lower amounts of HA (that presented higher shrinkage).
The mechanical properties were also not good, with
tensile strength and modulus decreasing with an
increase in HA amount (due to poor adhesion between
the ﬁller and the matrix). Microscopic examination
conﬁrmed these results, showing that HA particles were
intervening between the polymer chains, weakening
their interactions and decreasing the strength.
A composite of collagen and HA was developed as
bone substitute [321]. The collagen solution used was
shown to have been imbibed into the pores of HA and
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the high viscosity of these solutions, the pores were not
fully ﬁlled. The mechanical properties reﬂected this fact
and increased only until a certain concentration of col-
lagen. The decrease (at higher concentrations) was
attributed to the diﬃculty of ﬁlling the pores. The in
vitro degradation behaviour showed that degradation
roughly matched the growth rate of bone.
Yamaguchi et al. [314] used a co-precipitation method
to prepare the composites by using chitosan dissolved in
diﬀerent organic acids. They found that growth of HA
crystals was inhibited by organic acids with more than
two carboxyl groups, which strongly bind to HA sur-
faces via a COO–Ca+2 bond. Transmission electron
microscopy images showed that HA forms elliptic
aggregations with chemical interactions between cal-
cium on its surface and amino groups in chitosan
molecule (probably coordination bond); the HA nano-
crystals align along the chitosan molecules, with the
amino groups working as the nucleation sites. In case of
pure HA, the crystallites did not form aggregations.
Heat treatment at increased temperatures improved
strength and elongation to failure, but the modulus
decreased dramatically, making the composite less
suitable for orthopaedic applications. Finally, an
histological (preliminary) examination showed no
inﬂammation and appearance of new bone around the
composite.
Chitosan was also used as the matrix for the incor-
poration of b-TCP and calcium–phosphate invert glass
by a solid–liquid phase separation of the polymer solu-
tion and subsequent sublimation of the solvent [322].
The composites had improved compressive modulus
and strength (due to complexation of the functional
groups of chitosan with calcium ions present in b-TCP).
Only the composite with b-TCP was bioactive in SBF,
due to the nucleation sites provided by this ceramic.
These composites were suggested as suitable materials
for tissue engineering, with macroporous structures and
properties being adjusted by b-TCP/glass ratio and
ceramic/polymer ratio.
Another procedure used to prepare composites was
developed by Akashi and co-workers [323] by alter-
nately soaking hydrogels in calcium and phosphate
solutions during 2 h, and repeating this procedure 5
times, in order to produce HA on/in the hydrogels. The
procedure was applied to chitosan [324]; the 3-D shape
of the resulting composite was controlled by the shape
of the starting chitosan hydrogel and the swelling was
reduced with increase of the amount of incorporated
HA (up to 70% by weight of ceramic could be added to
the composites). Although this method is an improve-
ment to the previously referred coating of HA onto
polymers, because the formation of ceramic inside the
material could possibly provide strengthening, no
mechanical characterization was reported on that
particular work.5. Final remarks
Polymer matrix composites have the advantage of
being very versatile, allowing for the tailoring of its ﬁnal
properties. Composites can be designed and produced
with speciﬁc requirements, using a wide range of poly-
meric matrixes, reinforcements and processing routes.
Several alternatives have been proposed for both tem-
porary and permanent long-term applications. Further-
more, many injectable systems have been developed.
Most of these systems are typically biocompatible and
believed to be able to perform their function when
implanted. But it is also true that almost all of them
have some drawback. There is a great interest in con-
tinuing to explore the possibilities of those materials.
However, and in-spite of the fact that many patents
have been ﬁlled and granted in this ﬁeld, so far, no
relevant commercial application of composites in hard
tissue replacement is available in the market. It is the
authors’ opinion that new applications with a strong
clinical impact will be emerging soon, by means of
joining the eﬀorts on composite development, with new
inputs from the ﬁelds of nano-technology, biomimetics
and tissue engineering. In fact, novel generation biome-
dical composites are expected not to be conventional,
becoming hybrid, biofunctional and containing a
biological living part.References
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